SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes
Get Live Data
0.205    0.003 (1.49%)
Bid:
0.19
Ask:
0.22
Spread: 0.03 (15.789%)
Market Cap: £5.35m
NFX Live PriceLast checked at - London Stock Exchange

Intraday Nuformix Share Chart

Nuformix News

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix
29 Jan 2025

EARNINGS AND TRADING: S-Ventures loss narrows; charge knocks Nuformix

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday and not sepa...

TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal
13 Jan 2025

TRADING UPDATES: Eden Research in revenue rise; Cordel gets UK deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: Nuformix shares fall despite interim loss narrowing
18 Jun 2024

IN BRIEF: Nuformix shares fall despite interim loss narrowing

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Posts no revenue in the six months ended March 31...

Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment
17 Jun 2024

Nuformix touts patent wins for idiopathic pulmonary fibrosis treatment

(Alliance News) - Nuformix PLC on Monday celebrated multiple patent wins, after grants in both Europe and the US signalled further protections for its...

IN BRIEF: Nuformix announces subscription to raise GBP150,000
1 Mar 2024

IN BRIEF: Nuformix announces subscription to raise GBP150,000

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross proceeds of GBP...

IN BRIEF: Nuformix narrows annual loss as develops drug assets
3 Jan 2024

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months th...